- Home
- ENOV vs ATGE Comparison
ENOV vs ATGE Comparison
Compare ENOV & ATGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENOV
- ATGE
- Stock Information
- Founded
- ENOV 1995
- ATGE 1987
- Country
- ENOV United States
- ATGE United States
- Employees
- ENOV N/A
- ATGE N/A
- Industry
- ENOV Fluid Controls
- ATGE Other Consumer Services
- Sector
- ENOV Industrials
- ATGE Consumer Discretionary
- Exchange
- ENOV Nasdaq
- ATGE Nasdaq
- Market Cap
- ENOV 1.7B
- ATGE 4.4B
- IPO Year
- ENOV 2008
- ATGE 1991
- Fundamental
- Price
- ENOV $34.03
- ATGE $117.75
- Analyst Decision
- ENOV Strong Buy
- ATGE Strong Buy
- Analyst Count
- ENOV 5
- ATGE 3
- Target Price
- ENOV $55.60
- ATGE $135.67
- AVG Volume (30 Days)
- ENOV 1.6M
- ATGE 453.7K
- Earning Date
- ENOV 08-07-2025
- ATGE 08-07-2025
- Dividend Yield
- ENOV N/A
- ATGE N/A
- EPS Growth
- ENOV N/A
- ATGE 129.73
- EPS
- ENOV N/A
- ATGE 6.03
- Revenue
- ENOV $2,150,191,000.00
- ATGE $1,741,091,000.00
- Revenue This Year
- ENOV $8.23
- ATGE $14.09
- Revenue Next Year
- ENOV $6.18
- ATGE $6.36
- P/E Ratio
- ENOV N/A
- ATGE $19.88
- Revenue Growth
- ENOV 18.32
- ATGE 13.10
- 52 Week Low
- ENOV $28.83
- ATGE $67.30
- 52 Week High
- ENOV $49.83
- ATGE $140.12
- Technical
- Relative Strength Index (RSI)
- ENOV 54.37
- ATGE 38.78
- Support Level
- ENOV $32.74
- ATGE $118.54
- Resistance Level
- ENOV $36.82
- ATGE $123.85
- Average True Range (ATR)
- ENOV 1.31
- ATGE 3.94
- MACD
- ENOV 0.42
- ATGE -0.90
- Stochastic Oscillator
- ENOV 65.08
- ATGE 3.46
About ENOV Enovis Corporation
Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.
About ATGE Adtalem Global Education Inc.
Adtalem Global Education Inc is an American for-profit educational company that operates various university and educational programs. The company has three segments namely Chamberlain; Walden; and Medical and Veterinary. It derives maximum revenue from Chamberlain segment.